familial osteodysplasia, Anderson type
MeSH: C564923ORPHA: 27691 Treatment Available
Overview
human disease
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| Pamidronate | IV infusion, 30mg, 60mg, 90mg powder for reconstitution | FDA Approved | 10 | 7d |
Clinical Presentation
Signs and symptoms associated with familial osteodysplasia, Anderson type, sourced from HPO and Orphanet clinical annotations.
Malar flatteningMandibular prognathiaPointed chinAbnormal midface morphologyAbnormal earlobe morphologyBulbous noseProminent noseDepressed nasal ridgeThick eyebrowTooth malpositionHypertensionHyperuricemiaScoliosisIncreased susceptibility to fracturesRecurrent fracturesKyphosisAbnormal cortical bone morphologyLong noseAplasia/hypoplasia of the femurFailure of eruption of permanent teethAplastic clavicleLarge earlobeBifid femurAbnormal zygomatic bone morphologyCarious teethAbnormal rib morphologyMissing ribsAbnormal form of the vertebral bodiesClinodactyly of the 5th fingerSeizureElbow dislocation
Classification & Codes
MeSH Code
C564923Orphanet Code
ORPHA:2769familial osteodysplasia, Anderson type
| MeSH | C564923 |
| Orphanet | ORPHA:2769 |
| Treatments | 1 drug(s) |
| Symptoms on record | 31 signs |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO